HIF1A is a critical downstream mediator for hemophagocytic lymphohistiocytosis.
In conclusion, our data reveals that HIF1A signaling is a critical mediator for hemophagocytic lymphohistiocytosis and could be a novel therapeutic target for hemophagocytic lymphohistiocytosis.
PMID: 28860338 [PubMed - as supplied by publisher]
Source: Haematologica - Category: Hematology Authors: Huang R, Hayashi Y, Yan X, Bu J, Wang J, Zhang Y, Zhou Y, Tang Y, Wu L, Xu Z, Liu X, Wang Q, Zhou J, Xiao Z, Bridges JP, Marsh RA, Zhang K, Jordan MB, Li Y, Huang G Tags: Haematologica Source Type: research
More News: Anemia | Arthritis | Chemotherapy | Jordan Health | Middle East Health | Rheumatology | Thrombocytopenia | Toxicology